MH
Miraca Holdings
Venture CapitalModerateMiraca Holdings is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination.
5
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Miraca Holdings.
Investment Thesis & Strategy
Miraca Holdings invests in various stages of healthcare and hospital companies, specifically those involved in clinical testing and examination. They seek companies that manufacture and sell clinical test drugs.
Investment Activity
Deals per year over the last 9 years
2
20080
20092
20100
20110
20123
20131
20140
20151
2016Portfolio Companies
Selected investments from their portfolio of 5 companies
P
PathAI
AI/ML · Series A, 2016
G
Guardant Health
Biotech · Series C+, 2014
M
Myriad Genetics
Biotech · Growth, 2013
A
Adaptive Biotechnologies
Biotech · Series C+, 2013
I
Invitae
Biotech · Series A, 2013
B
Biocept
Biotech · Series A, 2010
V
Veracyte
Biotech · Series B, 2010
N
Natera
Biotech · Series A, 2008
N
NanoString Technologies
Biotech · Series B, 2008
Frequently Asked Questions
Miraca Holdings focuses on Series A, Series B, Series C+ stage investments.